Skip to main content
. 2023 Mar 11;12(1):13. doi: 10.1038/s41389-023-00453-7

Fig. 1. TRIM47 overexpression correlates with progression and poor prognosis in triple-negative breast cancer.

Fig. 1

A Kaplan–Meier analysis of relapse-free survival and distant metastasis free survival from a public dataset for breast cancer patients with low TRIM47 expression or high TRIM47 expression. B mRNA analysis of TRIM47 in TCGA public dataset for normal, no-triple-negative breast cancer and triple-negative breast cancer patients. C Real-time PCR(up) and WB(down) analysis of TRIM47 expression in 2 freshly collected normal, 4 no-triple-negative breast cancer and 4 triple-negative breast cancer tissues. D Real-time PCR(up) and WB(down) analysis of TRIM47 expression in 6 no-triple-negative breast cancer cells and 6 triple-negative breast cancer cells. E mRNA analysis of TRIM47 in GOBO public dataset for normal, no-triple-negative breast cancer and triple-negative breast cancer patients. Error bars represent the mean ± SD of three independent experiments. *P < 0.05; **P < 0.01; ***P < 0.001.